StonvexLoading…
StonvexStonvexStonvexCore line items from BLND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $123.58M | $91.17M | $58.47M | $26.84M |
Operating Income | $-21.73M | $-18.15M | $-12.81M | $-7.98M |
Net Income | $-6.80M | $-4.27M | $-16.36M | $-9.52M |
EPS (Diluted) | $-0.10 | $0.02 | $-0.07 | $-0.04 |
Total Assets | $170.04M | $188.61M | $182.19M | $187.47M |
Total Liabilities | $41.02M | $47.22M | $55.01M | $58.78M |
Cash & Equivalents | $43.58M | $55.02M | $36.50M | $56.24M |
Free Cash Flow OCF − CapEx | $-81.00K | $-60.00K | $5.70M | $15.80M |
Shares Outstanding | 256.04M | 259.23M | 259.00M | 258.83M |